ARCHIVES

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 37 No. 03 | January 21, 2011

Download PDF Visit The Full Archive

Related Articles

NCI plans 11-16 percent budget cuts in new grants to maintain R01 payline at 20th percentile.

November 28, 2003

Philadelphia Firm Wins CIDAC Award

August 24, 1984

DCT Board Okays Concepts Of Four New Grant Projects, Four Competitive Contract Delays Chlordane Study

March 9, 1984

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979

Cancer Control Survey “a Flop,” Advisory committee Members Say

October 11, 1974

Recision, 1981 Budget Threats Hangover NCI

March 14, 1980